Bausch Health Companies Inc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bausch Health Companies Inc with three other
pharmaceutical manufacturers in North America:
Vertex Pharmaceuticals Inc
of UNITED STATES
(2020
sales of $6.21 billion
of which 62%
was TRIKAFTA),
Zoetis Inc
of UNITED STATES
($6.68 billion
of which 53%
was US), and
Regeneron Pharmaceuticals Incorporated
which is
also
based in UNITED STATES
($8.50 billion
of which 58%
was EYLEA).
Sales Analysis.
During the year ended December of 2020, sales at
Bausch Health Companies Inc were C$10.75 billion (US$8.52 billion).
This
is
a
decrease of 5.5%
versus 2019, when the company's sales were C$11.38 billion.
Contributing to the drop in overall sales was the 7.8% decline
in U.S. Diversified Products Segment, from C$1.69 billion to C$1.56 billion.
There were also decreases in sales in
Bausch + Lomb / International Segment (down 5.9% to C$5.90 billion)
and
Salix (down 4.7% to C$2.55 billion)
and
Ortho Dermatologics (down 0.9% to C$740.58 million)
.